Bot MD and Surgical Oncology Society of the Philippines (SOSP) partners to launch Cancer Registry
(From L to R: Dr. Rodney B. Dofitas (SOSP, Vice President), Dr. Gemma Leonora B. Uy (SOSP, Secretary), Dorothea Koh (Bot MD, CEO and Co-Founder), Dr. Nelson D. Cabaluna (SOSP, President).
- The Cancer Registry was created in partnership with Bot MD and SOSP to help Filipino surgeons across 9 training institutions scale data collection across various regions of the Philippines into a single national database.
- Healthcare professionals, policymakers, researchers, and the public will have access to accurate and up-to-date information essential for advancing cancer care and improving patient outcomes.
Bot MD and Surgical Oncology Society of the Philippines (SOSP) are proud to announce their partnership to create the first National Cancer Registry for surgical oncology patients. The Bot MD Care platform will be used to help surgeons across 9 training institutions easily scale the data collection for their surgical cancer patients and to streamline analytics and tracking of 30-day mortality and long-term surveillance.
As cancer continues to be one of the leading causes of death in the Philippines, there is a pressing need for standardized data collection to be done at scale across various regions of the Philippines.
We want to help empower Filipino surgeons by making it easy for them to encode data about their cancer patients into a single registry. Bot MD is also able to integrate with any EMR platform to help to reduce the workload of encoding which will free up a busy doctor to focus on patient care. In addition, through standardizing data collection we will be able to provide aggregate analytics about the incidence and impact of cancer across the country.
Bot MD
The Surgical Oncology Society of the Philippines is honored to partner with Bot MD in the development and rollout of the National Cancer Registry to all our training academic institutions. This partnership will allow us to scale data collection in a standardized way and provide valuable insights into cancer demographics, trends, and outcomes, all to help advance the field of oncology in the Philippines.
Surgical Oncology Society of the Philippines
The Cancer Registry platform will contain a wide range of clinical information including morbidity and mortality data that will be essential for advancing cancer care and improving patient outcomes for many Filipino patients. Healthcare professionals, policymakers, researchers, and the public will be able to access a comprehensive overview of cancer incidence, prevalence, and treatment outcomes across various regions of the Philippines. This registry was made with the collaborative efforts of healthcare institutions, oncologists, surgeons, and data scientists of the SOSP and Bot MD.
Access to the Cancer Registry data will be available through the Surgical Oncology Society of the Philippines website at: https://sosp-org.com/.
For inquiries or further information, please contact: surgoncophil@gmail.com.
About Bot MD
Bot MD is a Y-Combinator backed startup with the mission of Empowering Doctors around the world. The company’s proprietary A.I. chat engine is able to integrate with hospital information systems to provide instant answers to doctor and patient queries. Bot MD can also power popular messaging platforms such as WhatsApp, Facebook Messenger, Viber and LINE to help doctors easily automate patient workflows. Since 2018, Bot MD has been used by over 20,000 clinicians from leading hospitals and clinics around the world including the National University Health System, the National University Cancer Institute, Singapore, Alexandra Hospital, Khoo Teck Puat Hospital, Changi General Hospital, Parkway Radiology, the National Kidney Transplant Institute and Siloam Hospitals. For more information, visit www.botmd.com
About the Surgical Oncology Society of the Philippines
Surgical Oncology Society of the Philippines (SOSP) is a value-centered specialty organization with recognized and respected experts in the management of cancer cases. It empowers its members to innovate and be the benchmark of excellence in the practice of surgical oncology in the world.